APIKA-MED, OOO, Novosibirsk Oblast

Accounting reports

Previously

Contacts

Name	APIKA-MED, OOO
INN	5404405629
KPP	543301001
OGRN	1095404024781
OKPO	64353888
Address	630526, Novosibirskaya Oblast', r-n Novosibirskiy, pr-d Avtomobilistov, d. D.10
Phone	Contact details

Extract from EGRUL $12 (€10)

Last name, first name & patronymic of the General Director

List of founders

Position of the company

Licenses

Authorized capital

Branches

Complete structure of the extract

Download an extract from EGRUL

We guarantee to provide you with an actual
information extract

OKVED code	Type	Name of activity type
Data on types of economic activities APIKA-MED, OOO according to EGRUL
20.42	Core activity	Manufacture of perfumes and cosmetics
10.85	Additional activity	Manufacture of prepared food products and dishes
21.20.1	Additional activity	Production of drugs
All types of activities
46.46.1	Additional activity	Wholesale of furniture, carpets and lighting equipment
47.73	Additional activity	Retailing drugs in specialized stores (pharmacies)
47.74	Additional activity	Retailing products used for medical purposes, orthopedic goods in specialized stores
47.75	Additional activity	Retailing of cosmetics and personal hygiene products in specialized stores

Registration information

Registration date	25.12.2009
Registering department	INSPEKTSIYA FNS ROSSII PO LENINSKOMU RAYONU G. NOVOSIBIRSKA

Description

APIKA-MED, OOO (Novosibirsk Oblast; INN 5404405629) was registered on 25 Dec 2009. The company's authorized capital as of July 1, 2012 was 11000 rub.

Type of ownership of APIKA-MED, OOO - Limited liability companies.

Form of ownership of APIKA-MED, OOO - Private property.

Principal activities of APIKA-MED, OOO: manufacture of perfumes and cosmetics (20.42), manufacture of prepared food products and dishes (10.85), production of drugs (21.20.1).

Industry

Economic indicators

2023

Net profit (RAS) of APIKA-MED, OOO dropped in 2023 by 30.83% to 5.53 million RUB from 8.00 million RUB over the same period in 2022, the company informed.

Revenue decreased in the accounting period by 15.67% to 75.19 million RUB from 89.17 million RUB in 2022; cost of goods sold decreased by 12.66% to 69.66 million RUB from 79.76 million RUB; sales profit fell by 41.21% to 5.53 million RUB from 9.41 million RUB.

2022

Net profit (RAS) of APIKA-MED, OOO grew over 2022 34.33 times to 8.00 million RUB from 233.00 thousand RUB over 2021, the company informed.

Revenue decreased in the accounting period by 3.94% to 89.17 million RUB from 92.83 million RUB in 2021; cost of goods sold decreased by 13.86% to 79.76 million RUB from 92.59 million RUB; sales profit went up 40.39 times to 9.41 million RUB from 233.00 thousand RUB.

2021

Net profit (RAS) of APIKA-MED, OOO dropped in 2021 39.87 times to 233.00 thousand RUB from 9.29 million RUB over the same period in 2020, the company informed.

Revenue increased in the accounting period by 32.89% to 92.83 million RUB from 69.85 million RUB over 2020; cost of goods sold grew 1.53 times to 92.59 million RUB from 60.57 million RUB; sales profit fell 39.87 times to 233.00 thousand RUB from 9.29 million RUB.

2020

Net profit (RAS) of APIKA-MED, OOO grew over 2020 2.49 times to 11.83 million RUB from 4.74 million RUB over 2019, the company informed.

Revenue increased in the accounting period 1.64 times to 98.98 million RUB from 60.53 million RUB over 2019; cost of goods sold grew 1.57 times to 88.69 million RUB from 56.41 million RUB; sales profit went up 2.49 times to 10.29 million RUB from 4.12 million RUB.

2018

Net profit (RAS) of APIKA-MED, OOO grew over 2018 1.88 times to 2.11 million RUB from 1.12 million RUB over 2017, the company informed.

Revenue decreased in the accounting period by 6.76% to 55.95 million RUB from 60.00 million RUB in 2017; cost of goods sold decreased by 13.88% to 50.46 million RUB from 58.60 million RUB; sales profit went up 1.88 times to 2.64 million RUB from 1.40 million RUB.

2017

Net profit (RAS) of APIKA-MED, OOO dropped in 2017 by 41.25% to 1.12 million RUB from 1.91 million RUB over the same period in 2016, the company informed.

Revenue increased in the accounting period by 19.68% to 60.00 million RUB from 50.13 million RUB over 2016; cost of goods sold grew by 22.73% to 58.60 million RUB from 47.75 million RUB; sales profit fell by 41.26% to 1.40 million RUB from 2.39 million RUB.

Financial Highlights

Revenue and earnings data

Daily subscription $39 (€32)

unlimited access to database "Kontragent"

download any information within 24 hours

Pay online

Companies in the region

Guarantees

We guarantee

provision of
relevant
information

Payment methods

Statistics

Companies

12 334 074

Reports

17 430 617

Rrocessed requests

Extract from EGRUL:

Today, 2:58 PM

Accounting reports:

Today, 3:01 PM